Skip to main content

Investors Tighten Grip On Venture Capital

As sources of money dry up, potential backers demand that science startups have prototypes to show off, if not products ready to roll PALO ALTO, CALIF.--For much of the eighties, software engineer Eric Hannah rode the roller coaster of venture capital funding for new high-tech startups in northern California. But after one rocketing success and one crashing failure, he's promised himself never to risk another ride. In fact, one of the things he likes most about the Silicon Valley company he's

Written byTa Heppenheimer
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00


As sources of money dry up, potential backers demand that science startups have prototypes to show off, if not products ready to roll
PALO ALTO, CALIF.--For much of the eighties, software engineer Eric Hannah rode the roller coaster of venture capital funding for new high-tech startups in northern California. But after one rocketing success and one crashing failure, he's promised himself never to risk another ride. In fact, one of the things he likes most about the Silicon Valley company he's now with is that it's not being bankrolled by venture capitalists.

"The problem with venture capital is that it's impatient money," says Hannah, a physicist who is now vice president of engineering at Palo Alto, Calif.-based Savitar. The two-year-old company, which designs software for electronic imaging with an emphasis on high-resolution color, relies on the personal assets of its founder, computer scientist Rudolph Burger.

Not every entrepreneur has sworn ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter
Engineering Bispecific Antibodies Against Emerging Viruses

Engineering Bispecific Antibodies Against Emerging Viruses

innovative-research-horizontal-lock-inverted-rgb-900px-w-72ppi

Products

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation

A photograph of plastic fragments floating in water, symbolizing contamination from sample storage tubes.

LVL SAFE® 2D-Coded Tubes: The Perfect Tube for Your Sample

AutoGen